Pharmaceutical Care for One Case of Nephrotic Syndrome Complicated with Pneumocystis carinii Pneumo-nia
10.6039/j.issn.1001-0408.2016.05.41
- VernacularTitle:1例肾病综合征合并肺孢子菌肺炎患者的药学监护
- Author:
Wenzhu ZHANG
;
Wenjie LI
;
Fusheng SUN
;
Yan ZHAO
- Publication Type:Journal Article
- Keywords:
Nephrotic syndrome;
Pneumocystis carinii pneumonia;
Clinical pharmacists;
Pharmaceutical care
- From:
China Pharmacy
2016;27(5):697-699
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the method and role of clinical pharmacists in pharmaceutical care for nephrotic syndrome complicated with Pneumocystis carinii pneumonia (PCP). METHODS:Clinical pharmacists participated in the treatment for a pa-tient with nephrotic syndrome complicated with PCP,and implemented pharmaceutical care in terms of the development of anti-in-fective therapy regimens,glucocorticoid optimization,guardianship for drug use,the medication education for patients. Clinical pharmacists provided suggestion that primary anti-infective plan of azithromycin 0.5 g,ivgtt,qd+Compound sulfalene tablet 2 tab-lets,po,q12 h;which was not effective,was adjusted plan as Compound sulfalene tablet 3 tablets,po,q6 h+clindamycin 0.6 g, ivgtt,q8 h+caspofungin 50 mg,ivgtt,qd. The dose of Methylprednisolone for injection was adjusted 4 times according to disease progression. RESULTS:Physicians adopted the suggestions of clinical pharmacists. After 30 days of treatment, lung abnormal le-sion was absorbed basically and infection control was achieved. CONCLUSIONS:Clinical pharmacists participate in anti-infective treatment and pharmaceutical care,and assist physicians to develop therapy plan to promote rational drug use in the clinic and im-prove the effectiveness and safety of clinical treatment.
